Key points are not available for this paper at this time.
Mycophenolate mofetil was superior to azathioprine in maintaining a renal response to treatment and in preventing relapse in patients with lupus nephritis who had a response to induction therapy. (Funded by Vifor Pharma formerly Aspreva; ALMS ClinicalTrials.gov number, NCT00377637.).
Dooley et al. (Thu,) studied this question.